Developments in pharmacological therapy for the overactive bladder

被引：9

作者：

Chapple, Christopher R.

Gormley, E. Ann

机构：

[1] Sheffield Hallam Univ, Dept Urol, Sheffield Teaching Hosp, NHS Fdn Trust, Sheffield 510 2JF, S Yorkshire, England

[2] Dartmouth Hitchcock Med Ctr, Sect Urol, Lebanon, NH USA

来源：

BJU INTERNATIONAL | 2006年 / 98卷

关键词：

overactive bladder; pharmacotherapy; detrusor overactivity; cholinergic-muscarinic receptors; adrenoceptor; agonist; antagonist; anticholinergics; vanilloids; botulinum toxin; RAT URINARY-BLADDER; QUALITY-OF-LIFE; DETRUSOR SMOOTH-MUSCLE; ANTIMUSCARINIC AGENT SOLIFENACIN; SELECTIVE RECEPTOR ANTAGONIST; EXTENDED-RELEASE FORMULATIONS; CARBACHOL-INDUCED CONTRACTION; BOTULINUM-TOXIN; CONTROLLED TRIAL; AUTONOMOUS ACTIVITY;

D O I：

10.1111/j.1464-410X.2006.06381.x

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：78 / 87

页数：10

共 96 条

[61] Multiple functional defects in peripheral autonomic organs in mice lacking muscarinic acetylcholine receptor gene for the M3 subtype
Matsui, M
Motomura, D
Karasawa, H
Fujikawa, T
Jiang, J
Komiya, Y
Takahashi, S
Taketo, MM
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (17) : 9579 - 9584
[62] Matsui M, 2002, J NEUROSCI, V22, P10627
[63] Kit positive cells in the guinea pig bladder
McCloskey, KD
Gurney, AM
[J]. JOURNAL OF UROLOGY, 2002, 168 (02) : 832 - 836
[64] Botulinal neurotoxins:: revival of an old killer
Montecucco, C
Molgó, J
[J]. CURRENT OPINION IN PHARMACOLOGY, 2005, 5 (03) : 274 - 279
[65] THE ACTION-POTENTIAL AND NET MEMBRANE CURRENTS IN ISOLATED HUMAN DETRUSOR SMOOTH-MUSCLE CELLS
MONTGOMERY, BSI
FRY, CH
[J]. JOURNAL OF UROLOGY, 1992, 147 (01) : 176 - 184
[66] Muscarinic M2 receptors inhibit Ca2+-activated K+ channels in rat bladder smooth muscle
Nakamura, T
Kimura, J
Yamaguchi, O
[J]. INTERNATIONAL JOURNAL OF UROLOGY, 2002, 9 (12) : 689 - 696
[67] NORONHABLOB L, 1991, J PHARMACOL EXP THER, V256, P562
[68] Urge incontinence - Quality of life and patients' valuation of symptom reduction
O'Conor, RM
Johannesson, M
Hass, SL
Kobelt-Nguyen, G
[J]. PHARMACOECONOMICS, 1998, 14 (05) : 531 - 539
[69] The M2 muscarinic receptor mediates in vitro bladder contractions from patients with neurogenic bladder dysfunction
Pontari, MA
Braverman, AS
Ruggieri, MR
[J]. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2004, 286 (05) : R874 - R880
[70] A comparison of extended-release oxybutynin and tolterodine for treatment of overactive bladder in women
Sand, PK
Miklos, J
Ritter, H
Appell, R
[J]. INTERNATIONAL UROGYNECOLOGY JOURNAL, 2004, 15 (04) : 243 - 248

← 1 2 3 4 5 6 7 8 9 10 →